ARMISTICE CAPITAL, LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 74 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2018$13,384,000
-3.3%
1,836,000
+8.8%
1.02%
-25.8%
Q4 2017$13,842,000
-21.9%
1,688,0000.0%1.38%
-33.9%
Q3 2017$17,724,000
+39.7%
1,688,000
+46.8%
2.09%
+29.1%
Q2 2017$12,685,000
+37.1%
1,150,000
+20.3%
1.62%
-15.4%
Q1 2017$9,254,000956,0001.91%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q1 2017
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 2,305,017$18,625,0007.73%
COWEN AND COMPANY, LLC 3,732,778$30,161,0002.74%
GENDELL JEFFREY L 2,446,299$19,766,0001.60%
Asymmetry Capital Management, L.P. 369,134$2,983,0001.58%
Vivo Capital, LLC 2,937,093$23,732,0001.43%
Samsara BioCapital, LLC 659,409$5,328,0001.03%
Altium Capital Management LP 440,589$3,560,0000.98%
Knott David M Jr 258,198$2,086,0000.71%
RTW INVESTMENTS, LP 5,741,939$46,395,0000.68%
FRAZIER MANAGEMENT LLC 951,814$7,691,0000.59%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders